List of Excipients in API METHYLPREDNISOLONE SODIUM SUCCINATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing METHYLPREDNISOLONE SODIUM SUCCINATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pharmacia & Upjohn Company LLC | SOLU-MEDROL | methylprednisolone sodium succinate | 0009-0698 | BENZYL ALCOHOL | |
| Pharmacia & Upjohn Company LLC | SOLU-MEDROL | methylprednisolone sodium succinate | 0009-0698 | SODIUM PHOSPHATE, DIBASIC | |
| Pharmacia & Upjohn Company LLC | SOLU-MEDROL | methylprednisolone sodium succinate | 0009-0698 | SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | |
| Pharmacia & Upjohn Company LLC | SOLU-MEDROL | methylprednisolone sodium succinate | 0009-0758 | SODIUM PHOSPHATE, DIBASIC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing METHYLPREDNISOLONE SODIUM SUCCINATE
Detailed excipient profiles for METHYLPREDNISOLONE SODIUM SUCCINATE
Excipient focus: BENZYL ALCOHOL
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing BENZYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | methylprednisolone sodium succinate | 0009-0698 |
| Fresenius Kabi USA LLC | methylprednisolone sodium succinate | 63323-265 |
| REMEDYREPACK INC | methylprednisolone sodium succinate | 70518-3128 |
| >Company | >Ingredient | >NDC |
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing BENZYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing LACTOSE MONOHYDRATE
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: SODIUM HYDROXIDE
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM HYDROXIDE
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE DIBASIC DIHYDRATE
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | methylprednisolone sodium succinate | 0143-9182 |
| Hikma Pharmaceuticals USA Inc | methylprednisolone sodium succinate | 0143-9850 |
| >Company | >Ingredient | >NDC |
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM PHOSPHATE DIBASIC DIHYDRATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM PHOSPHATE, DIBASIC
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM PHOSPHATE, DIBASIC
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Cardinal Health 107 LLC | methylprednisolone sodium succinate | 55154-3939 |
| >Company | >Ingredient | >NDC |
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | methylprednisolone sodium succinate | 43598-127 |
| REMEDYREPACK INC | methylprednisolone sodium succinate | 70518-3684 |
| >Company | >Ingredient | >NDC |
METHYLPREDNISOLONE SODIUM SUCCINATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
